THOMAS W BURKE to Neoplasm Staging
This is a "connection" page, showing publications THOMAS W BURKE has written about Neoplasm Staging.
Connection Strength
0.376
-
Developing a system to track meaningful outcome measures in head and neck cancer treatment. Head Neck. 2014 Feb; 36(2):226-30.
Score: 0.039
-
A prospective phase II study of chemoradiation followed by adjuvant chemotherapy for FIGO stage I-IIIA (1988) uterine papillary serous carcinoma of the endometrium. Gynecol Oncol. 2013 May; 129(2):304-9.
Score: 0.038
-
The origins of multidisciplinary cancer care. Gynecol Oncol. 2008 Sep; 110(3 Suppl 2):S2-3.
Score: 0.028
-
Heterogeneity of stage IIIA endometrial carcinomas: implications for adjuvant therapy. Int J Gynecol Cancer. 2005 May-Jun; 15(3):510-6.
Score: 0.022
-
Utility of lymphangiography in the prediction of lymph node metastases in patients with cervical cancer. Int J Gynecol Cancer. 2002 Nov-Dec; 12(6):755-9.
Score: 0.019
-
Early cervical cancer. Curr Treat Options Oncol. 2000 Jun; 1(2):147-55.
Score: 0.016
-
The current status of surgical staging of ovarian serous borderline tumors. Cancer. 1999 Feb 15; 85(4):905-11.
Score: 0.014
-
Surgical therapy of T1 and T2 vulvar carcinoma: further experience with radical wide excision and selective inguinal lymphadenectomy. Gynecol Oncol. 1995 May; 57(2):215-20.
Score: 0.011
-
Histologic characterization of uterine papillary serous adenocarcinoma. Gynecol Oncol. 1995 Mar; 56(3):425-9.
Score: 0.011
-
Clinical aspects of risk in women with endometrial carcinoma. J Cell Biochem Suppl. 1995; 23:131-6.
Score: 0.011
-
Metastatic cervical cancer presenting as cholecystitis. Gynecol Oncol. 1994 Aug; 54(2):250-3.
Score: 0.010
-
High-stage endometrioid carcinoma of the ovary. Prognostic significance of pure versus mixed histologic types. Am J Surg Pathol. 1994 Jul; 18(7):687-93.
Score: 0.010
-
Limited endometrial carcinoma: adjuvant therapy. Semin Oncol. 1994 Feb; 21(1):84-90.
Score: 0.010
-
Aggressive stage I grade 1 endometrial carcinoma. Cancer. 1992 Aug 15; 70(4):790-8.
Score: 0.009
-
Factors affecting recurrence and survival in stage I carcinoma of the uterine cervix. Oncology (Williston Park). 1992 Feb; 6(2):111-6; discussion 118-9; 122.
Score: 0.009
-
A phase II trial of paclitaxel and carboplatin in women with advanced or recurrent uterine carcinosarcoma. Int J Gynecol Cancer. 2011 Apr; 21(3):517-22.
Score: 0.008
-
Evaluation of the scalene lymph nodes in primary and recurrent cervical carcinoma. Gynecol Oncol. 1987 Nov; 28(3):312-7.
Score: 0.007
-
The use of adjuvant radiation therapy in patients with intermediate-risk Stages IC and II uterine corpus cancer: a patient care evaluation study from the American College of Surgeons National Cancer Data Base. Gynecol Oncol. 2005 Dec; 99(3):530-5.
Score: 0.006
-
Practice patterns of SGO members for stage IIIA endometrial cancer. Gynecol Oncol. 2005 Jul; 98(1):77-83.
Score: 0.006
-
The activity of taxanes compared with bleomycin, etoposide, and cisplatin in the treatment of sex cord-stromal ovarian tumors. Gynecol Oncol. 2005 May; 97(2):489-96.
Score: 0.006
-
Increased plasma levels of insulin-like growth factor 2 and insulin-like growth factor binding protein 3 are associated with endometrial cancer risk. Cancer Epidemiol Biomarkers Prev. 2004 May; 13(5):748-52.
Score: 0.005
-
Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases. Gynecol Oncol. 2003 Dec; 91(3):463-9.
Score: 0.005
-
Groin recurrence in patients with vulvar cancer with negative nodes on superficial inguinal lymphadenectomy. Gynecol Oncol. 2003 Sep; 90(3):625-8.
Score: 0.005
-
Sarcomatoid carcinoma of the cervix. Gynecol Oncol. 2003 Jul; 90(1):23-8.
Score: 0.005
-
Treatment of uterine papillary serous carcinoma with paclitaxel. Gynecol Oncol. 2001 Jul; 82(1):156-61.
Score: 0.004
-
Radiation treatment of advanced or recurrent granulosa cell tumor of the ovary. Gynecol Oncol. 1999 Apr; 73(1):35-41.
Score: 0.004
-
Ovarian serous borderline tumors with invasive peritoneal implants. Cancer. 1998 Mar 15; 82(6):1096-103.
Score: 0.003
-
Prognostic significance of residual disease in patients with stage IV epithelial ovarian cancer. Gynecol Oncol. 1997 Jan; 64(1):13-7.
Score: 0.003
-
Treatment of poor-prognosis sex cord-stromal tumors of the ovary with the combination of bleomycin, etoposide, and cisplatin. Obstet Gynecol. 1996 Apr; 87(4):527-31.
Score: 0.003
-
Potential applications of intraoperative lymphatic mapping in vulvar cancer. Gynecol Oncol. 1995 Nov; 59(2):216-20.
Score: 0.003
-
Adenocarcinoma as an independent risk factor for disease recurrence in patients with stage IB cervical carcinoma. Gynecol Oncol. 1995 Oct; 59(1):38-44.
Score: 0.003
-
Prolonged continuous infusion cisplatin and 5-fluorouracil with radiation for locally advanced carcinoma of the vulva. Gynecol Oncol. 1995 Oct; 59(1):51-6.
Score: 0.003
-
Staging laparotomy for endometrial carcinoma: assessment of retroperitoneal lymph nodes. Gynecol Oncol. 1995 Aug; 58(2):189-93.
Score: 0.003
-
Low-stage clear-cell carcinoma of the endometrium. Am J Surg Pathol. 1995 Jul; 19(7):769-74.
Score: 0.003
-
Ovarian malignant mixed m?llerian tumors treated with platinum-based chemotherapy. Obstet Gynecol. 1995 May; 85(5 Pt 1):735-9.
Score: 0.003
-
Treatment of locally advanced cervical cancer with concurrent radiation and intra-arterial chemotherapy. Gynecol Oncol. 1995 Apr; 57(1):72-8.
Score: 0.003
-
Staging laparotomy for endometrial carcinoma: assessment of peritoneal spread. Gynecol Oncol. 1995 Jan; 56(1):34-8.
Score: 0.003
-
Hemorrhagic cystitis following radiotherapy for stage Ib cancer of the cervix. Gynecol Oncol. 1994 Nov; 55(2):206-10.
Score: 0.003
-
Radical hysterectomy for recurrent carcinoma of the uterine cervix after radiotherapy. Gynecol Oncol. 1994 Oct; 55(1):29-35.
Score: 0.003
-
Prognostic factors for patients undergoing simple hysterectomy in the presence of invasive cancer of the cervix. Gynecol Oncol. 1993 Aug; 50(2):179-84.
Score: 0.002
-
Stage I cervical adenocarcinoma: prognostic evaluation of surgically treated patients. Gynecol Oncol. 1993 Apr; 49(1):19-23.
Score: 0.002
-
Treatment of small cell carcinoma of the cervix with cisplatin, doxorubicin, and etoposide. Gynecol Oncol. 1992 Oct; 47(1):62-5.
Score: 0.002
-
Minimally invasive vulvar carcinoma: an indication for conservative surgical therapy. Gynecol Oncol. 1992 Mar; 44(3):240-4.
Score: 0.002
-
Early stage I adenocarcinoma of the uterine cervix: treatment results in patients with tumors less than or equal to 4 cm in diameter. Gynecol Oncol. 1991 Jun; 41(3):199-205.
Score: 0.002
-
Unsuspected invasive squamous cell carcinoma of the vulva in young women. Gynecol Oncol. 1991 May; 41(2):182-5.
Score: 0.002
-
Prognostic factors in stage IB squamous cervical cancer patients with low risk for recurrence. Obstet Gynecol. 1991 Feb; 77(2):271-5.
Score: 0.002
-
Treatment of fallopian tube carcinoma with cisplatin, doxorubicin, and cyclophosphamide. Obstet Gynecol. 1990 Dec; 76(6):1020-4.
Score: 0.002
-
Endometrioid carcinoma of the ovary: retrospective review of 145 cases. Gynecol Oncol. 1990 Dec; 39(3):337-46.
Score: 0.002
-
Estrogen replacement therapy following treatment for stage I endometrial carcinoma. Gynecol Oncol. 1990 Feb; 36(2):189-91.
Score: 0.002
-
Determinants of survival of patients with epithelial ovarian carcinoma following whole abdomen irradiation (WAR). Gynecol Oncol. 1988 Jun; 30(2):201-8.
Score: 0.002